what are glp 1 agonist Evolution of GLP‐1 Receptor Agonists for Diabetes Treatment Comparing Ozempic, Wegovy and Other

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are increasingly prescribed among plastic surgery patients for obesity and overweight

Given the heterogeneity of the included evidencespanning case reports, pharmacovigilance analyses, and observational cohortsthis review is framed primarily as a signal-detection and evidence-mapping exercise rather than a causal-inference analysis

The science behind 24% weight loss results explained.

Although dedicated trials of GLP-1RAs in AITD are lacking, preliminary reports suggest potential impacton thyroid volume, thyroid function, and autoimmune activity

However, most (59%) of same those employers say their cost for the drugs has exceeded expectations

Policy and Global Health Policy advances in 2025 laid critical groundwork for the next phase of obesity care